Search research articles
Contact Us
Filters
Showing results (231-240 of 241) with videos related to
Page
of 25
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 2, 2008
Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR)
Hillard M Lazarus, Jeanette Carreras, Christian Boudreau, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 14, 2009
Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma
Timothy S Fenske, Parameswaran N Hari, Jeanette Carreras, et al.
Blood
|
November 29, 2002
A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma
John E Levine, Richard E Harris, Fausto R Loberiza, et al.
NPJ Precision Oncology
|
May 27, 2021
Targeting the epichaperome as an effective precision medicine approach in a novel PML-SYK fusion acute myeloid leukemia
Mayumi Sugita, David C Wilkes, Rohan Bareja, et al.
European Heart Journal
|
March 20, 2023
Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipients
Syed S Mahmood, Peter A Riedell, Stephanie Feldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 19, 2024
Randomized Phase III SIERRA Trial of <sup>131</sup>I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AML
Boglarka Gyurkocza, Rajneesh Nath, Stuart Seropian, et al.
Blood
|
September 26, 2013
Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI
Edward A Copelan, Betty K Hamilton, Belinda Avalos, et al.
The New England Journal of Medicine
|
May 11, 2012
Lenalidomide after stem-cell transplantation for multiple myeloma
Philip L McCarthy, Kouros Owzar, Craig C Hofmeister, et al.
The Lancet. Haematology
|
August 23, 2017
Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial
Sarah A Holstein, Sin-Ho Jung, Paul G Richardson, et al.
JCO Precision Oncology
|
October 9, 2019
Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer
Verena Sailer, Kenneth Wa Eng, Tuo Zhang, et al.
Page
of 25
Search research articles
Search
Showing results (231-240 of 241) with videos related to
Sort By:
Page
of 25
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 2, 2008
Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR)
Hillard M Lazarus, Jeanette Carreras, Christian Boudreau, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 14, 2009
Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma
Timothy S Fenske, Parameswaran N Hari, Jeanette Carreras, et al.
Blood
|
November 29, 2002
A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma
John E Levine, Richard E Harris, Fausto R Loberiza, et al.
NPJ Precision Oncology
|
May 27, 2021
Targeting the epichaperome as an effective precision medicine approach in a novel PML-SYK fusion acute myeloid leukemia
Mayumi Sugita, David C Wilkes, Rohan Bareja, et al.
European Heart Journal
|
March 20, 2023
Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipients
Syed S Mahmood, Peter A Riedell, Stephanie Feldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 19, 2024
Randomized Phase III SIERRA Trial of <sup>131</sup>I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AML
Boglarka Gyurkocza, Rajneesh Nath, Stuart Seropian, et al.
Blood
|
September 26, 2013
Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI
Edward A Copelan, Betty K Hamilton, Belinda Avalos, et al.
The New England Journal of Medicine
|
May 11, 2012
Lenalidomide after stem-cell transplantation for multiple myeloma
Philip L McCarthy, Kouros Owzar, Craig C Hofmeister, et al.
The Lancet. Haematology
|
August 23, 2017
Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial
Sarah A Holstein, Sin-Ho Jung, Paul G Richardson, et al.
JCO Precision Oncology
|
October 9, 2019
Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer
Verena Sailer, Kenneth Wa Eng, Tuo Zhang, et al.
Page
of 25